Skip to Main Content

Go to Main Navigation


Year Established:
Salem, Massachusetts, US
Company Type:
Small Business (1-10M TTM Revenue)

Genoskin is a biotech company with research facilities in Toulouse, France, and Boston (USA). The company specializes in first-in-human data generation for the biotech, pharma as well as cosmetic and consumer goods industry.
Genoskin has developed the world’s first ex vivo platform to test the toxicity and efficacy of drug candidates, including biologics or small molecules, that are administered by intradermal or subcutaneous injections.
Leveraged by artificial intelligence and machine learning, Genoskin’s human skin platforms generate actionable human data ahead of clinical trials to significantly reduce the costs, duration and risks inherent in drug development
To do so, we use patented technologies to bio-stabilize, in a functional survival state, discarded human skin tissue obtained from plastic procedures. Our living and immunocompetent ex vivo human skin models are closest to what can be seen during clinical trials and are a reliable alternative to animal testing.

Site Badges
Genoskin Inc.
4 Technology Way Salem, Massachusetts, 01970 United States
1 place Pierre Potier Toulouse, France, 31100 France

Get started

To request access, simply fill out the form below and we will contact you.

Password must:

• Be at least 12 characters in length

• Contain a lowercase letter (a-z)

• Contain an uppercase letter (A-Z)

• Contain a numeral (0-9)

• Contain a special character (%, $, !, @)